All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
Hosted on MSN
6m
Eisai and Biogen’s Leqembi sBLA set for Alzheimer’s maintenance dosing
The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...
Pharm Exec
59m
FDA Approves Supplemental Biologics License Application for Intravenous Maintenance Dosing of Leqembi in Alzheimer Disease
Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Tech stocks fall
Taliban envoy warns Rubio
Car plows into Eagles fans
NY state trooper surrenders
Suspect to appear in court
Texas nightclub shooting
Immigration raids across TX
Swaps Pepsi for Coca-Cola
Graham on Jan. 6 pardons
To limit public schedule
House explosion in W.Va.
Colombia tariffs paused
ND trans care ban trial
‘Flight Risk’ tops box office
Belarus releases US citizen
SK plane crash probe
Lilleberg faces NHL hearing
New OC for Seahawks
Won't review MS voting ban
Air Force reinstates course
Sinner wins Australian Open
Israel permits Gaza return
Proposes TikTok merger
Emil Bove visits Chicago
NK tested cruise missiles?
Chiefs beat Bills
Eagles defeat Commanders
Israel, Lebanon extend truce
Related topics
Biogen
Leqembi
Alzheimer's disease
Food and Drug Administration
Lenvatinib
Feedback